🫁 EGFR-Mutation Targeted Therapy (Osimertinib) Simulator

The simulator illustrates the mechanism of osimertinib, a third-generation tyrosine kinase inhibitor that blocks mutant EGFR receptors (including T790M resistance mutation), in non-small cell lung cancer.

2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install